Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02825485
Other study ID # 19030
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date July 27, 2016
Est. completion date May 24, 2019

Study information

Verified date September 2021
Source University of Virginia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

It has previously been found that there is no correlation between degree of hydronephrosis and presence of reflux; however this is oftentimes the criteria physicians use to obtain a VCUG.


Description:

Investigators conducted a previous retrospective study to evaluate other possible findings on ultrasound that may better predict reflux. Investigators found that if a postnatal ultrasound showed any of the three findings of hydroureter, duplication or dysmorphic kidney, then the odds ratio of detecting reflux was 8.07 (95%CI 3.86, 16.87). The purpose of this study is to perform a randomized prospective study to validate this retrospective study. Investigators hypothesis is that patients with hydronephrosis alone will be more likely to have negative VCUG studies; hence obtaining a VCUG for this indication may not be warranted.


Recruitment information / eligibility

Status Terminated
Enrollment 24
Est. completion date May 24, 2019
Est. primary completion date May 24, 2019
Accepts healthy volunteers No
Gender All
Age group N/A to 5 Years
Eligibility Inclusion Criteria: - Patients with a history of antenatal hydronephrosis who have a post-natal ultrasound demonstrating hydronephrosis alone and no other abnormalities Exclusion Criteria: - Patients with a post-natal ultrasound demonstrating bilateral hydronephrosis - Patients with a history of posterior urethral valve or when a valve is suspected - Patients who have hydronephrosis on ultrasound as well as other findings including duplication, hydroureter, dysmorphic kidneys, or bladder abnormalities

Study Design


Intervention

Procedure:
Voiding cystourethrogram


Locations

Country Name City State
United States University of Virginia Health System, Pediatric Urology, Battle Bldg Charlottesville Virginia

Sponsors (1)

Lead Sponsor Collaborator
University of Virginia

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Development of UTIs Through study completion, an average of 4 years
Secondary The rate of reflux detected on VCUGs Through study completion, an average of 4 years
Secondary Rate of resolution of hydronephrosis Through study completion, an average of 4 years